MD Anderson Researchers Highlight Advances in Clinical Studies at the AACR Annual Meeting 2021
April 12, 2021
April 12, 2021
HOUSTON, Texas, April 12 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 11, 2021:
Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer.
The results, presented today at the virtual American Association for Cancer Research (AACR . . .
Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer.
The results, presented today at the virtual American Association for Cancer Research (AACR . . .